AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are ...
Under the Chandelier at Mar-a-Lago, Trump Makes Picks at Breakneck Speed President-elect Trump is more contemptuous than ever of Washington expertise and determined to hire people based on loyalty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback